Product image of Flutor© (Fludeoxyglucose (18f)) supplied by GNH India

Flutor©

Active Ingredient:
Fludeoxyglucose (18f)
Origin:
EU

Flutor© (Fludeoxyglucose (18f))

Fludeoxyglucose (18F) is a radiopharmaceutical used in positron emission tomography (PET) scans to detect metabolic activity in the body. It helps in diagnosing and monitoring various conditions by highlighting areas of high glucose metabolism.

Manufacturer / TM Owner

Dtz Radiochemie Am Frankfurter Tor Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Fludeoxyglucose (18F) is primarily used in PET imaging to identify areas of high metabolic activity. This can be helpful in detecting cancer, evaluating heart function, and assessing brain activity. It is often used to monitor the progression of diseases and the effectiveness of treatments.

Side Effects

  • Fludeoxyglucose (18F) works by being absorbed by cells with high metabolic rates, which can then be visualized using PET scans. This helps in identifying areas of concern within the body. The effects are typically temporary and related to the imaging process.

Precautions & Warnings

  • Fludeoxyglucose (18F) should be handled with care due to its radioactive nature. It is important to follow safety protocols to minimize exposure. Patients should inform their healthcare provider about any allergies or medical conditions before undergoing a PET scan.

Avoid Interactions

  • Fludeoxyglucose (18F) may interact with certain medications or substances that affect glucose metabolism. It is advisable to discuss all current medications with a healthcare provider before undergoing a PET scan. Alcohol and certain foods may also affect the accuracy of the scan.

Frequently Asked Questions

Fludeoxyglucose (18F) is used in PET scans to detect areas of high metabolic activity, often for diagnosing and monitoring conditions like cancer and heart disease.

Fludeoxyglucose (18F) is administered intravenously before a PET scan to allow the radiopharmaceutical to be absorbed by the body's tissues.

Common effects may include temporary discomfort at the injection site or mild allergic reactions, but these are generally rare and short-lived.

It is typically recommended to fast for a certain period before the scan, as food and drink can affect the accuracy of the results.

The effects of Fludeoxyglucose (18F) are temporary and usually last only for the duration of the PET scan.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Fludeoxyglucose (18f)

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT